Premature ovarian failure: An update

Fertility and Sterility

Volumn 70, Issue 1, 1998, Pages 1-15

  Anasti, James N ^a,b  

^a ST LUKE S HOSPITAL   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Ovarian dysfunction; Ovarian physiology; Premature ovarian failure

Indexed keywords

CONJUGATED ESTROGEN; CYTOKINE; DANAZOL; ESTRADIOL; ETHINYLESTRADIOL; GESTAGEN; GONADORELIN DERIVATIVE; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

AMENORRHEA; AUTOIMMUNE DISEASE; ENZYME DEFICIENCY; FEMALE; GALACTOSEMIA; HORMONE SUBSTITUTION; HUMAN; ORAL DRUG ADMINISTRATION; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE MATURATION; OVARY INSUFFICIENCY; PREGNANCY RATE; PRIORITY JOURNAL; RADIATION INJURY; REMISSION; REVIEW; SEX CHROMOSOME ABERRATION; THYMECTOMY; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0032125452     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00099-5     Document Type: Article

References (100)

1. 1. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-6.
2. 2. Atria A. La menopausia precoz y tratamiento hormonal. Rev Med Chil 1950;78:373-7.
3. 3. Jones GS, de Moraes-Ruehsen M. A new syndrome of amenorrhea in association with hypergonadotropism and apparently normal ovarian follicular apparatus. Am J Obstet Gynecol 1969;104:597-600.
4. 4. Goldenberg RL, Grodin RL, Rodbard D, Ross GT. Gonadotropins in women with amenorrhea. Am J Obstet Gynecol 1973;116:1003-9.
5. 5. Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril 1990;53:804-10.
6. 6. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996;65: 337-41.
7. 7. Nelson LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994;79:1470-5.
8. 8. Mehta AE, Matwijiw I, Lyons EA, Faiman C. Noninvasive diagnosis of resistant ovary syndrome by ultrasonography. Fertil Steril 1992;57: 56-61.
9. 9. Adashi EY. The ovarian follicular apparatus. In: Adashi EY, Rock JA, Rosenwaks Z, editors. Reproductive endocrinology, surgery, and technology. 1st ed. New York: Lippincott-Raven, 1995:17-40.
10. 10. Amsterdam A, Dantes A, Selvaraj N, Aharoni D. Apoptosis in steroidogenic cells: structure-function analysis. Steroids 1997;62:207-11.
11. 11. Kaipia A, Hsueh AJ. Regulation of ovarian follicle atresia. Annu Rev Physiol 1997;59:349-63.
12. 12. Billig H, Chun SY, Eisenhauer K, Hsueh AJ. Gonadal cell apoptosis: hormone-regulated cell demise. Hum Reprod Update 1996;2:103-17.
13. 13. Manova K, Bachvarova RF. Expression of c-kit at the W locus of mice in developing embryonic germ cells and presumptive melanoblasts. Dev Biol 1991;146:312-24.
14. 14. Duncan MK, Lieman J, Chada KK. The germ cell deficient locus maps to mouse chromosome 11A2-3. Mamm Genome 1995;6:697-9.
15. 15. Paller AS. Ataxia-telangiectasia. Neurol Clin 1987;5:447-9.
16. 16. Healy DL, Bacher J, Hodgen GD. Thymic regulation of primate fetal ovarian-adrenal differentiation. Biol Reprod 1985;32:1127-33.
17. 17. Zinn AR, Page DC, Fisher EM. Turner syndrome: the case of the missing sex chromosome. Trends Genet 1993;9:90-3.
18. 18. Sarto GE, Therman E, Patau K. X inactivation in man: a woman with t(Xq-;12q+). Am J Hum Genet 1973;25:262-70.
19. 19. Krauss CM, Turksoy RN, Atkins L, McLaughlin C, Brown LG, Page DC. Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N Engl J Med 1987;317:125-31.
20. 20. Powell CM, Taggart RT, Drumheller TC, Wangsa D, Qian C, Nelson LM, et al. Molecular and cytogenetic studies of an X;autosome translocation in a patient with premature ovarian failure and review of the literature. Am J Med Genet 1994;52:19-26.
21. 21. Partington MW, Moore DY, Turner GM. Confirmation of early menopause in fragile X carriers. Am J Med Genet 1996;64:370-2.
22. 22. Mattison DR, Evans MI, Schwimmer WB, White BJ, Jensen B, Schulman JD. Familial premature ovarian failure. Am J Hum Genet 1984;36:1341-8.
23. 23. Waggoner DD, Buist NRM, Donnell GN. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis 1990;13:802-18.
24. 24. Chen YT, Mattison DR, Feigenbaum I, Fukui H, Schulman JD. Reduction in oocyte number following prenatal exposure to a diet high in galactose. Science 1981;214:1145-7.
25. 25. Levy HL, Driscoll SG, Porensky RS, Wender DF. Ovarian failure in galactosemia. N Engl J Med 1984;310:50.
26. 26. Prestoz LL, Couto AS, Shin YS, Petry KG. Altered follicle stimulating hormone isoforms in female galactosaemia patients. Eur J Pediatr 1997;156:116-20.
27. 27. Kaufman FR, Reichardt JK, Ng WG, Xu YK, Manis FR, McBride-Chang C, et al. Correlation of cognitive, neurologic, and ovarian outcome with the Q188R mutation of the galactose-1-phosphate uridyltransferase gene. J Pediatr 1994;125:225-7.
28. 28. Apperly JF, Reddy N. Mechanism and management of treatment-related gonadal failure in recipients of high dose chemotherapy. Blood Rev 1995;9:93-116.
29. 29. Morris ID, Shalet SM. Protection of gonadal function from cytotoxic chemotherapy and irradiation. Bailieres Clin Endocrinol Metab 1990; 4:97-118.
30. 30. Newton H, Aubard Y, Rutherford A, Sharma V, Gosden RG. Low temperature storage and grafting of human ovarian tissue. Hum Reprod 1996;11:1487-91.
31. 31. Thibaud E, Ramirez M, Brauner R, Flamant F, Zucker JM, Fekete C, et al. Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. J Pediatr 1992;121: 880-4.
32. 32. Cooper GS, Baird DD, Hulka BS, Weinberg CR, Savitz DA, Hughes CL. Follicle-stimulating hormone concentrations in relation to active and passive smoking. Obstet Gynecol 1995;85:407-11.
33. 33. Yanase T, Sanders D, Shibata A, Matusi N, Simpson ER, Waterman MR. Combined 17alpha hydroxylase/17,20 lyase deficiency due to a 7-basepair duplication in the N-terminal region of the cytochrome P450. J Clin Endocrinol Metab 1990;70:1325-31.
34. 34. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80:3689-98.
35. 35. Rabinovici J, Blankstein J, Goldman B, Rudak E, Dor Y, Pariente D, et al. In vitro fertilization and primary embryonic cleavage are possible in 17α-hydroxylase deficiency despite extremely low intrafollicular 17β-estradiol. J Clin Endocrinol Metab 1989;68:693-7.
36. 36. Layman LC, Lee EJ, Peak DB, Namnoum AB, Vu KV, van Lingen BL, et al. Brief report: delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone β-subunit gene. N Engl J Med 1997;337:607-11.
37. 37. Latronico AC, Anasti J, Arnhold IJ, Rapaport R, Mendonca BB, Bloise, et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 1996;334:507-12.
38. 38. Aittomaki K, Herva R, Stenman UH, Juntunen K, Ylostalo P, Hovatta O, et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab 1996;81:3722-6.
39. 39. Wolfsdorf JI, Rosenfield RL, Fang VS, Kobayashi R, Razdan AK, Kim MH. Partial gonadotrophin-resistance in pseudohypoparathyroid-ism. Acta Endocrinol 1978;88:321-8.
40. 40. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997;18:107-34.
41. 41. Guinet P, Pommatau E. Le pseudo-panhypopituitarisme par insuffisiences associees ovarienne, thyroidienne, et semenale. Ann Endocrinol (Paris) 1954;15:327-32.
42. 42. Betterle C, Rossi A, Dalla Pria S, Artifoni A, Pedini B, Gavasso S, et al. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol 1993;39:35-43.
43. 43. LaBarbera AR, Miller MM, Ober C, Rebar RW. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol 1988;16:115-22.
44. 44. Kim TJ, Anasti JN, Flack MR, Kimzey LM, Defensor RA, Nelson LM. Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1997; 89:777-9.
45. 45. Moncayo R, Moncayo HE. Premature ovarian failure: evidence of the immunologic component. In: Ovarian autoimmunity: clinical and experimental data. 1st ed. Austin, TX: RG Landes Co., 1995:27-75.
46. 46. Vallotton MB, Forbes AP. Antibodies to cytoplasm of ova. Lancet 1966;2:264-5.
47. 47. Kim JG, Anderson BE, Rebar RW, LaBarbera AR. A biotin-streptavidin enzyme immunoassay for detection of antibodies to porcine granulosa cell antigens. J Immunoassay 1991;12:447-64.
48. 48. Wheatcroft NJ, Toogood AA, Li TC, Cooke ID, Weetman AP. Detection of antibodies to ovarian antigens in women with premature ovarian failure. Clin Exp Immunol 1994;96:122-8.
49. 49. Chiauzzi V, Cigorraga S, Escobar ME, Rivarola MA, Charreau EH. Inhibition of follicle-stimulating hormone receptor binding by circulating immunoglobulins. J Clin Endocrinol Metab 1982;54:1221-8.
50. 50. van Weissenbruch MM, Hoek A, van Vlietbleeker I, Schoemaker J, Drexhage H. Evidence for existence of immunoglobulins that block ovarian granulosa cell growth in vitro. A putative role in resistant ovary syndrome. J Clin Endocrinol Metab 1991;73:360-7.
51. 51. Tilly JL, Aihara T, Nishimori K, Jia XC, Billig H, Kowalski KI, et al. Expression of recombinant human follicle-stimulating hormone receptor: species-specific ligand binding, signal transduction, and identification of multiple ovarian messenger ribonucleic acid transcripts. Endocrinology 1992;131:799-806.
52. 52. Anasti JN, Flack MR, Froehlich J, Nelson LM. The use of human recombinant gonadotropin receptors to search for immunoglobulin G-mediated premature ovarian failure. J Clin Endocrinol Metab 1995; 80:824-8.
53. 53. Sluss PM, Schneyer AL. Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients. J Clin Endocrinol Metab 1992;74:1242-6.
54. 54. Irvine WJ, Chan MMW, Scarth L. The further characterization of autoantibodies reactive with extra-adrenal steroid-producing cells in patients with adrenal disorders. Clin Exp Immunol 1969;4:489-503.
55. 55. Ahonen P, Miettinen A, Perheentupa J. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 1987;64:494-500.
56. 56. McNatty KP, Short RV, Barnes EW, Irvine EW. The cytotoxic effect of serum from patients with Addison's disease and autoimmune ovarian failure on human granulosa cell in culture. Clin Exp Immunol 1975;22:378-84.
57. 57. Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, et al. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab 1996;81:1871-6.
58. 58. Norman RJ, Brannstrom M. White cells and the ovary - incidental invaders or essential effectors? J Endocrinol 1994; 140:333-6.
59. 59. Sedmak DD, Hart WR, Tubbs RR. Autoimmune oophoritis: a histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate. Int J Gynecol Pathol 1987; 6:73-81.
60. 60. Hill JA, Welch WR, Faris HMP, Anderson DJ. Induction of class II major histocompatibility complex antigen expression in human granulosa cells by interferon gamma: a potential mechanism contributing to autoimmune ovarian failure. Am J Obstet Gynecol 1990;162:534-40.
61. 61. Tidey GF, Nelson LM, Phillips TM, Stillman RJ. Gonadotropins enhance HLA-DR antigen expression in human granulosa cells. Am J Obstet Gynecol 1992;167:1768-73.
62. 62. Friedman CI, Gurgen-Varol F, Lucas J, Neff J. Persistent progesterone production associated with autoimmune oophoritis. J Reprod Med 1987;32:293-6.
63. 63. Ho PC, Tang GW, Lawton JW. Lymphocyte subsets and serum immunoglobulins in patients with premature ovarian failure before and after oestrogen replacement. Hum Reprod 1993;8:714-6.
64. 64. Pekonen F, Siegberg R, Makinen T, Miettinen A, Yli-Korkala O. Immunological disturbances in patients with premature ovarian failure. Clin Endocrinol 1986;25:1-6.
65. 65. Mignot MH, Drexhage HA, Kleingeld M, Van de Plassche-Boers EM, Rao BR, Schoemaker J. Premature ovarian failure. II: Considerations of cellular immunity defects. Eur J Obstet Gynecol Reprod Biol 1989;30:67-72.
66. 66. Morris RS, Sauer MV. New advances in the treatment of infertility in women with ovarian failure. Curr Opin Obstet Gynecol 1993;5:368-77.
67. 67. Anasti JN, Adams S, Kimzey LM, Defensor RA, Zachary AA, Nelson LM. Karyotypically normal spontaneous premature ovarian failure: evaluation of association with the class II major histocompatibility complex. J Clin Endocrinol Metab 1994;78:722-3.
68. 68. Ahonen P, Koskimies S, Lokki ML, Tiilikainen A, Perheentupa J. The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR. J Clin Endocrinol Metab 1988;66:1152-7.
69. 69. Skinner SM, Mills T, Kirchick HJ, Dunbar BS. Immunization with zona pellucida proteins results in abnormal ovarian follicular differentiation and inhibition of gonadotropin-induced steroid secretion. Endocrinology 1984;115:2418-32.
70. 70. Rhim SH, Millar SE, Robey F, Luo Am, Luo YH, Yule T, et al. Autoimmune disease of the ovary induced by a ZP3 peptide from the mouse zona pellucida. J Clin Invest 1992;89:28-35.
71. 71. Luo AM, Garza KM, Hunt D, Tung KS. Antigen mimicry in autoimmune disease: x sharing of amino acid residues critical for pathogenic T cell activation. J Clin Invest 1993;92:2117-23.
72. 72. Nishizuka Y, Sakakura T. Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 1969;166:753-5.
73. 73. Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice II. J Exp Med 1982; 156:1577-86.
74. 74. Taguchi O, Nishizuka Y. Autoimmune oophoritis in thymectomized mice: T cell requirement in adoptive cell transfer. Clin Exp Immunol 1980;42:324-31.
75. 75. Coulam CB, Stringfellow S, Hoefnagel D. Evidence for a genetic factor in the etiology of premature ovarian failure. Fertil Steril 1983; 40:693-5.
76. 76. Plouffe L, McDonough PG. Ovarian agenesis and dysgenesis. In: Adashi EY, Rock JA, Rosenwaks Z, editors. Reproductive endocrinology, surgery, and technology. 1st ed. New York: Lippincott-Raven, 1995:1365-84.
77. 77. Nishi Y, Hamamoto K, Kajiyama M, Kawamura I. The Perrault syndrome: clinical report and review. Am J Med Genet 1988;31: 623-9.
78. 78. Amati P, Gasparini P, Zlotogora J, Zelante L, Chomel JC, Kitzis A, et al. A gene for premature ovarian failure associated with eyelid malformation maps to chromosome 3q22-q23. Am J Hum Genet 1996; 58:1089-92.
79. 79. Allanson JE, Hall JG. Obstetric and gynecologic problems in women with chondrodystrophies. Obstet Gynecol 1986;67:74-8.
80. 80. Scott RT Jr, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril 1995;63:1-11.
81. 81. Farhi J, Homburg R, Ferber A, Orvieto R, Ben Rafael Z. Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Hum Reprod 1997; 12:241-3.
82. 82. Daneshdoost L, Gennarelli TA, Bashey HM, Savino PJ, Sergoot RC, Bosley TM, et al. Recognition of gonadotroph adenomas in women. N Engl J Med 1991;324:589-94.
83. 83. Blumenfeld Z, Halachmi S, Peretz BA, Shmuel Z, Golan D, Makler A, et al. Premature ovarian failure - the prognostic application of autoimmunity on conception after ovulation induction. Fertil Steril 1993; 59:750-5.
84. 84. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women. J Am Med Assoc 1995;273:199-208.
85. 85. Lobo RA. Benefits and risks of estrogen replacement therapy. Am J Obstet Gynecol 1995;173:982-9.
86. 86. Marty JP. New trends in transdermal technologies: development of the skin patch, Menorest. Int J Gynaecol Obstet 1996;52(Suppl 1):S17-20.
87. 87. Anasti JN, Kimzey LM, Defensor RA, White B, Nelson LM. A controlled study of danazol for the treatment of karyotypically normal spontaneous premature ovarian failure. Fertil Steril 1994;62:726-30.
88. 88. Nelson LM, Kimzey LM, White BJ, Merriam GR. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled trial. Fertil Steril 1992;57: 50-5.
89. 89. Luborsky JL, Visintin I, Boyers S, Asari T, Caldwell B, DeCherney A. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab 1990;70:69-75.
90. 90. Corenblum B, Rowe T, Taylor PJ. High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil Steril 1993;59:988-91.
91. 91. Check JH, Nowroozi K, Chase JS, Nazari A, Shapse D, Vaze M. Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea. Fertil Steril 1990;53:811-6.
92. 92. Fitch JP, De Saint Victor J, Richer C, Pinsky L, Sitahal S. Premature menopause due to a small deletion in the long arm of the X chromosome: a report of three cases and a review. Am J Obstet Gynecol 1982;142:968-72.
93. 93. Franco Junior JG, Baruffi RL, Mauri AL, Pertersen CG, Campos MS, Oliveira JB. Donation of oocytes as treatment for infertility in patients with premature ovarian failure. Rev Paul Med 1994;112:510-6.
94. 94. Pados G, Camus M, Van Waesberghe L, Liebaers I, Van Steirteghem A, Devroey P. Oocyte and embryo donation: evaluation of 412 consecutive trials. Hum Reprod 1992;7:111-7.
95. 95. Sung L, Bustillo M, Mukherjee T, Booth G, Karstaedt A, Copperman AB. Sisters of women with premature ovarian failure may not be ideal ovum donors. Fertil Steril 1997;67:912-6.
96. 96. Cui KH. Genome project and human reproduction. Hum Reprod 1995;10:1275-9.
97. 97. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
98. 98. Rizzo LV, Caspi RR. Immunotolerance and prevention of ocular autoimmune disease. Curr Eye Res 1995; 14:857-64.
99. 99. Hsueh AJ, Eisenhauer K, Chun SY, Hsu SY, Billig H. Gonadal cell apoptosis. Recent Prog Horm Res 1996;51:433-55.
100. 100. Nelson LM, Anasti JN, Flack MR. Premature ovarian failure. In: Adashi Ey, Rock JA, Rosenwaks Z, editors. Reproductive endocrinology, surgery, and technology. 1st ed. New York: Lippincott-Raven, 1995:1393-410.